Source: PRWeb Remarkable progress in the development of cell and gene therapies (CGTx) has ignited hope for millions of patients battling debilitating human diseases including Central
Source: PM360online Enhancing patient engagement in rare disease support programs requires tailored strategies that leverage innovative approaches, including AI and decentralized trials: Personalized Communication: Utilize
Source– BioProcess International The infusion of artificial intelligence (AI) technology in drug development has led to transformative solutions to age-old challenges, reshaping the trajectory from
Source: IG Living Magazine Research and development of orphan drugs is time-consuming and costly, and appropriate participants for clinical trials are hard to find. Efficiently
Source: PR Web President Biden’s loss of his beloved son to brain cancer in 2015 inspired the Cancer Moonshot initiative. Dr. Harsha Rajasimha’s inspiration for
Innovative technologies have revolutionized how clinical trials are conducted, catering to a diverse range of participants while ensuring patient-centricity remains a top priority. Embracing decentralized
Clinical trial sponsors need reliable patient data to ensure compliance and adhere to the regional and national guidelines. While the complexities persist in clinical trials,
The need for greater patient engagement isn’t a new issue today. It has persisted for decades, and the struggle to optimize it is still a
In the bustling world of clinical research, where every discovery holds the promise of a brighter future, patient engagement and compliance stand as the guiding
Source: Telehealth and Medicine Today Clinical trials, the bedrock of medical research, are facing a pervasive challenge that threatens the very foundation of therapeutic development:
Jeeva Clinical Trials Inc.
